Top Markets
#1 0G 0G +32.75%
#2 Zora Zora +23.49%
#3 Nockchain Nockchain +20.21%
#4 Fake World Assets Fake World Assets +19.05%
#5 Axelar Axelar +18.61%
#6 Full Moon Full Moon +17.70%
#7 Merlin's Seal BTC Merlin's Seal BTC +15.95%
#8 Notcoin Notcoin +15.90%
#9 ADO Protocol ADO Protocol +15.68%
#10 SAFEcoin SAFEcoin +14.51%
Coin of the day
0G 0G
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

KYTX
Classifica tra le azioni #13175
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Prezzo delle azioni
$8.46
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$514.33M
Variazione (1 giorno)
-2.08%
Variazione (1 anno)
128.03%
Paese
US
Scambia Kyverna Therapeutics, Inc. (KYTX)

Categoria

Healthcare
Storico del prezzo dell'azione per Kyverna Therapeutics, Inc. (KYTX)
Prezzo di chiusura più alto: $8.33 il 2026-08-01

Prezzo di chiusura più basso: $28.70 il 2024-02-01
Storico del prezzo dell'azione di Kyverna Therapeutics, Inc. dal 2024 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -5.16%
2025 89.56%
2024 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $752.76 6.28%
CH